IQInvest research note
26 SEP 2026 · 01:28 ET
CVS
CVS Health Corporation
$89.13
$4.08 (+4.80%)up 4.80%
26 September 2026 · delayed 15+ min
F
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
CVS Health Corporation earns a F on strong earnings growth (>20%) and positive free cash flow but current ratio below 1.0 (liquidity concerns) and high debt-to-equity ratio (>2.0). Consider alternatives with better risk/reward profiles.
Adjusted for Moderate investors, Medium-term investors 3.4% suggested allocation Change these
IQ-CVS-20260926engine v1 · 7-category weighted scorecard